SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Milestone Scientific Reports 200%+ Q2 Medical Revenue Growth

Milestone Scientific reported 200%+ growth in Q2 2026 medical segment revenue and detailed commercial expansion of its CompuFlo epidural system, citing more than 500 U.S. leads, reimbursement access and international distribution.

MLSS
SquawkNews Desk

Milestone Scientific reported 200%+ growth in Q2 2026 medical segment revenue and detailed commercial expansion of its CompuFlo epidural system, citing 500+ U.S. leads, reimbursement access, and international distribution.Material DetailsContext by AI AnalystThis is an early-to-mid stage commercial…

Related stories

Australian Energy Stocks Reach One-Week High as Oil Rises Australian energy stocks reached a one-week high as supply concerns lifted oil prices. M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC Nasdaq 100 futures fall 2%; S&P 500 futures down almost 1% M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC U.S. Stock Futures Fall as Intel and Amazon Earnings Weigh At 11:44 p.m. EDT, Dow futures fell 0.17%, S&P 500 futures fell 0.95% and Nasdaq-100 futures fell more than 2% after disappointing earnings from Intel and Amazon. M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC Janome to Buy Back Up to 5.98% of Shares L impact | EQUITY | Oct 30, 2026, 04:02 AM UTC Asian session market picture: S&P 500 -0.94%, Nasdaq 100 -2.06%; USD/JPY -0.15%, WTI +1.18%, 1810 leads volume Asian session market picture. US index futures: S and P futures is down 0.94 percent, Nasdaq futures is down 2.06 percent, Dow futures is down 0.19 percent and Russell futures is d M impact | EQUITY | Oct 30, 2026, 04:00 AM UTC Hengsheng Real Estate Delisted on Nov. 3 Hengsheng Real Estate’s listing status was formally revoked on Nov. 3. L impact | EQUITY | Oct 30, 2026, 03:59 AM UTC